1. GBp

    4,412

    Today's change

    -14.05 / -0.32%

    1 year change

    +34.08%

    As of Jul 23 2014 07:21 BST. Data delayed by at least 15 minutes.

Search for AstraZeneca PLC and
  1. 11 hours ago

    US warned of up to 25 groups eyeing foreign switch to cut tax

    Up to 25 more US companies are considering relocating overseas to cut their tax bills this year, a Democratic senator has...

  2. July 18, 2014

    AstraZeneca unveils plans for £330m R&D centre in Cambridge

    AstraZeneca’s commitment to UK science was at the heart of its defence against Pfizer’s £69bn takeover bid in May. Two...

Special Reports

  1. 50 Top Business Ideas

    The FT puts the spotlight on which inventions and innovations have helped to create to...
  2. Engineering the Future

    Many of the world’s most exciting companies have engineering innovation at their heart...
Search more Special Reports on this topic.

  1. July 16, 2014

    Eli Lilly joins forces with UK biotech to develop cancer drugs

    Eli Lilly has entered the race to develop a new generation of oncology drugs, which harness the immune system to kill cancer...

  2. July 16, 2014

    David Cameron moves to boost UK life sciences

    The appointment of George Freeman in a newly created life sciences role in Tuesday’s reshuffle marks the prime minister’s...

  3. July 14, 2014

    AbbVie/Shire - join us at 12 for a live discussion

    The above is a clause from the Medtronic/Covidien merger agreement of course – although it allows Medtronic to walk away...

  4. July 13, 2014

    Vince Cable plans to toughen up takeover rules

    Vince Cable plans to strengthen Britain’s takeover rules to make it harder for international bidders to renege on promises...

  5. July 8, 2014

    Cable backtracks on move to protect science industry

    Vince Cable has signalled the coalition will resist the Labour party’s demands for stronger government powers to intervene...

  6. July 8, 2014

    AbbVie avoids Pfizer errors in bear hug against Shire

    My pals are bigger than your pals. AbbVie has resorted to an old playground intimidation tactic, by implying a majority of...

  7. July 7, 2014

    Woodford goes big on AstraZeneca in new fund

    Neil Woodford, one of Britain’s most celebrated fund managers, has revealed that drugmaker AstraZeneca is the largest...

  8. July 2, 2014

    Drug groups welcome UK push to tackle superbugs

    Drugmakers have welcomed the appointment of Jim O’Neill, the former Goldman Sachs chief economist, to lead a UK...

  9. July 1, 2014

    AstraZeneca chief increases stake in drugmaker

    AstraZeneca’s chief executive has signalled his confidence in the company’s prospects by buying £2m worth of its shares,...

  10. June 29, 2014

    Global dealmaking shows return to vigour

    It was with qualified optimism that Ian Read, Pfizer’s chief executive, boarded his private jet to London on the penultimate...

  11. Business Blog

    June 27, 2014

    Defensive play in the World Cup of corporate taxation

    The global system for taxing multinational companies is broken, but no country wants to alter it too radically for fear of...

  12. June 26, 2014

    Not all AGM protests are centred on executive pay

    Exactly a year ago, Li Ruigang was one of the most unpopular directors at any FTSE 100 company – at least as far as...

  13. June 20, 2014

    AstraZeneca set to bolster takeover defences

    AstraZeneca is considering selling the rights to some of its future revenues in a move that would boost the UK drugmaker’s...

  14. June 18, 2014

    David Cameron launches world’s biggest dementia study

    The world’s biggest study of dementia will be unveiled by David Cameron on Thursday as part of a push worth more than £100m...

  15. June 17, 2014

    Major pharmaceutical groups may be too big to succeed

    As Pfizer eyed a £70bn takeover of AstraZeneca this spring, the prospective deal highlighted an awkward truth for the chief...

  16. June 16, 2014

    UK biotech groups’ rush to market injects sense of optimism

    Britain’s biotech sector has experienced more false dawns than most industries. But after a barren decade, a series of deals...

  17. June 15, 2014

    Time moves slowly for biotech investors

    Scientists are supposed to alight upon miraculous cures in a eureka moment. But, in reality, it usually takes years to make...

  18. June 12, 2014

    AstraZeneca in $232m asthma drug deal

    AstraZeneca has struck a deal worth up to $232m with a UK biotech company to develop a new asthma drug, highlighting its...

  19. June 11, 2014

    A new approach is needed for British dealmaking

    Many countries have liberalised their takeover regimes in the past three decades. Thanks to this and the impact of...

  20. June 10, 2014

    Better life for insurers as pensions megadeals take off

    Another month, another pensions insurance megadeal. Total this week unveiled an agreement to insure three-fifths of its...

  21. June 8, 2014

    Japanese drugmakers sit out global M&A party

    Japanese drugmakers have been conspicuous by their absence from the dealmaking bonanza sweeping the sector across Europe and...

  22. MBA blog

    June 4, 2014

    The siren song of innovation revisited

    The last few weeks have been busy with learning all about mergers and acquisitions and international finance as a part of my...

  23. June 3, 2014

    AstraZeneca seeks to bring new cancer drugs to market

    AstraZeneca claims to have demonstrated the potential “to transform the way cancer is treated” as it steps up efforts to...

  24. June 3, 2014

    Loan caps too weak to curb runaway London prices

    The correlation between proliferating property porn and rising London house prices cannot have escaped the notice of Royal...

  25. June 2, 2014

    Top pay at FTSE 100 groups still rising despite restraint rules

    Executive pay at the UK’s biggest companies is still rising despite new rules intended to encourage pay restraint, according...

  26. June 1, 2014

    AstraZeneca chief questions linking his pay to £55 share target

    AstraZeneca’s chief executive has questioned calls for his pay to be linked to achieving the £55 share price that was...

  27. June 1, 2014

    Beneficial owners suffer from ‘democratic deficit’

    Pharmaceutical company Pfizer’s proposed £69bn takeover of UK rival AstraZeneca may have come to an end, for now at least,...

  28. May 30, 2014

    Corporate citizens of the world owe fealty to us all

    The head of a British multinational declared this week that he opposed the idea of companies that exist “somewhere in the...

  29. May 30, 2014

    What happens when the family bows out?

    At the time of my last column, the bidding for AstraZeneca was only just getting going and the initial public offering...

  30. May 30, 2014

    Hopes for cancer cures offer comfort for battered pharma

    It is the Holy Grail of medical science. Ever since Hippocrates, the Greek physician, first described the disease more than...

  31. May 30, 2014

    AstraZeneca’s resistance efforts rely on cancer drug advances

    After spending weeks defending itself against a near-£70bn takeover approach from Pfizer, AstraZeneca hopes data to be...

  32. May 29, 2014

    Judgment of  Solomons should be to spurn Marcato

    Squeaky wheels don’t always merit greasing. Shareholder Marcato Capital has suggested that InterContinental Hotels Group,...

  33. May 29, 2014

    UK lesson for Stryker and Pfizer

    Twice in two weeks, US companies interested in buying UK groups have walked away after coming up against British takeover...

  34. May 28, 2014

    The regulators were right to force Pfizer’s hand

    Pfizer has announced that it will not, after all, be making an offer for AstraZeneca. By contrast, four years ago another...

  35. May 27, 2014

    Gold miners retreat on precious metals fall

    Gold miners slipped after strong US economic data, including rising durable goods orders and consumer sentiment, sent the...

  36. May 27, 2014

    Labour to push for tougher rules on takeovers before election

    Labour is to push for tougher takeover rules to be introduced before the next election as it takes up the cause of defending...

  37. May 26, 2014

    Pfizer admits defeat in AstraZeneca bid

    Pfizer has admitted defeat in its pursuit of AstraZeneca, bringing an end to a month-long takeover battle that pitted two of...

  38. May 25, 2014

    Pfizer: plan B

    What is plan B? Probably plan A again. UK Takeover Panel rules say that Pfizer can have another shot at AstraZeneca in three...

Search for AstraZeneca PLC and

RELATED VIDEOS

Videos from FT.com that closely match this topic

  1. Lex on the rejection of Pfizer's ‘final’ bid...
    May 19, 2014

    Lex on the rejection of Pfizer's ‘final’ bid

  2. The FT debates Pfizer's takeover bid for AstraZeneca...
    May 13, 2014

    The FT debates Pfizer's takeover bid for AstraZeneca

  3. CEO Pascal Soriot on AstraZeneca's move to Cambridge...
    July 3, 2013

    CEO Pascal Soriot on AstraZeneca's move to Cambridge